Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Approves Drug That Extends Lung Cancer Survival

December 15, 2014 1:36 pm | by University of California, Los Angeles | News | Comments

The FDA approved a new drug to treat non-small-cell lung cancer offering people new hope in fighting the disease. Read more...                       

TOPICS:

Scientists Reveal Neurotransmitter Binding-Site Function

December 15, 2014 1:15 pm | by Ellen Goldbaum, University of Buffalo | News | Comments

New research from University at Buffalo scientists will help pharmacologists better understand how drugs work and how to make them more effective. Read more...                 

TOPICS:

Medication Being Studied Could Help Afib Patients After Stroke

December 15, 2014 1:03 pm | by University of South Florida | News | Comments

Researchers are studying the effectiveness of a new rapid-onset anticoagulant medication with the standard anticoagulant drug in stroke patients with atrial fibrillation, the most common type of abnormal heart rhythm. Read more...     

TOPICS:
Advertisement

Cancer Patients Testing Drugs on Mouse Avatars

December 15, 2014 12:56 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

The idea is to see which drugs might work best on a specific person's specific cancer. Read more...                           

TOPICS:

Anthera Licenses Japan Rights for Blisibimod to Zenyaku

December 15, 2014 11:11 am | News | Comments

Anthera Pharmaceuticals, Inc. announced that Anthera and Zenyaku Kogyo Co., Ltd. of Tokyo, Japan executed an exclusive license agreement for the development and commercialization of subcutaneous blisibimod in Japan and potentially other countries throughout Asia.  Read more...

TOPICS:

Tackling One of The Biggest Questions in Dementia Research

December 15, 2014 11:06 am | by University of Southampton | News | Comments

Researchers in Southampton are tackling one of the biggest questions in dementia research; why might current approaches in Alzheimer's trials be failing? The new study is published in the Journal of Pathology and funded by Alzheimer's Research UK and the Medical Research Council. Read more...

TOPICS:

UN Commission Asks for Ebola Debt Forgiveness

December 15, 2014 11:00 am | by Associated Press | News | Comments

A U.N. commission is asking for more debt cancellations for the three West African nations hardest hit by the Ebola virus. The United Nations Economic Commission for Africa said that it is crucial that the current Ebola health crisis not be a catalyst for financial distress in Sierra Leone, Guinea and Liberia. Read more..

TOPICS:

Roche Expands CE-IVD Claims For Organ, Tissue Testing

December 15, 2014 10:55 am | News | Comments

Roche announced that the cobas MPX and cobas WNV assays can now be used for testing of human organ and tissue from cadaveric (non-heart beating) donors, expanding the range of approved uses for the cobas 6800/8800 Systems and assays in markets accepting the CE mark. Read more...

TOPICS:
Advertisement

OPKO, Pfizer Enter Into Global Agreement for hGh

December 15, 2014 10:44 am | News | Comments

OPKO Health, Inc. and Pfizer Inc. announced that they have entered into a worldwide agreement for the development and commercialization of OPKO’s long-acting hGH-CTP for the treatment of growth hormone deficiency (GHD) in adults and children, as well as for the treatment of growth failure in children born small for gestational age (SGA) who fail to show catch-up growth by 2 years of age. Read more...

TOPICS:

Potential Hepatitis B Cure Enters Clinical Trial

December 15, 2014 8:52 am | News | Comments

A new treatment promoting the cure of chronic hepatitis B is now recruiting patients for clinical trials. Read more....                        

TOPICS:

Key Human Gene Modifies Immune Response to Flu Vaccine

December 12, 2014 11:24 am | News | Comments

How much protection the annual flu shot provides depends on how well the vaccine (which is designed based on a "best guess" for next season's flu strain) matches the actually circulating virus. However, it also depends on the strength of the immune response elicited by the vaccine. Read more...

TOPICS:

J&J Collaborates with Janssen,USAID to Expand Access to MDR-TB Compound

December 12, 2014 11:15 am | News | Comments

Johnson & Johnson today announced that its affiliate Janssen Therapeutics, Division of Janssen Products, LP (Janssen), has signed a Memorandum of Understanding (MOU) representing the intention of the Company along with the United States Agency for International Development (USAID) to step up the fight against the health threat of antibiotic-resistant bacteria. Read more...

TOPICS:

CA Battles Whooping Cough Epidemic

December 12, 2014 11:07 am | News | Comments

California officials are battling the worst whooping cough epidemic to hit the state in seven decades as a recent rebound in cases raises questions about the effectiveness of the pertussis vaccine. Read more...                    

TOPICS:

Taming Inflammatory Response in Kidney Dialysis

December 12, 2014 11:02 am | News | Comments

Over the past several years, lead author John Lambris, PhD, the Dr. Ralph and Sallie Weaver Professor of Research Medicine, Perelman School of Medicine at the University of  Pennsylvania, and his colleagues have developed small molecule versions of the drug compstatin, which inhibits a component of the complement immune response called C3. Read more...

TOPICS:

Hep C Ruled Out as Mental Impairment Cause in HIV

December 12, 2014 10:52 am | by Michael C. Purdy, Washington University | News | Comments

Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer. As they age, however, many experience impaired thinking, memory loss, mood swings and other evidence of impaired mental function. Read more... 

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading